These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32206556)

  • 1. The prognostic effect of TTF-1 expression in the Chinese population of patients with advanced lung adenocarcinomas.
    Li X; Yin L; Zhao Y; He M; Qi Q; Sun Y; Li H; Evison M; ;
    Transl Lung Cancer Res; 2020 Feb; 9(1):82-89. PubMed ID: 32206556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
    Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
    Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
    Doherty MK; O'Connor E; Hannon D; O'Reilly A; Yen D; Redmond M; Grogan LM; Hennessy BT; Breathnach OS; Morris PG
    Ir J Med Sci; 2019 Feb; 188(1):69-74. PubMed ID: 29948461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Results of TTF-1 Immunostaining on Efficacy of Platinum-Doublet Chemotherapy in Japanese Patients with Nonsquamous Non-Small-Cell Lung Cancer.
    Nakao A; Inoue H; Ikeuchi N; Igata F; Aoyama T; Hamasaki M; Arima H; Fujita M
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of TTF-1 expression in stage I adenocarcinoma.
    Zhou C; Zhao J; Shao J; Li W
    Oncotarget; 2017 Dec; 8(64):107462-107468. PubMed ID: 29296178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].
    Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
    Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
    Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
    BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
    Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
    Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thyroid transcription factor-1 in differentiating lung adenocarcinomas from non-pulmonary adenocarcinoma effusions.
    Khidir LS; Abdelwadoud ME; Abdelmola A; Babiker NE; Elemam IB; Elmahi OM; Alharthi NS; Waggiallah HA
    J Med Life; 2023 Jun; 16(6):932-936. PubMed ID: 37675165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid transcription factor-1 expression in advanced non- small cell lung cancer: impact on survival outcome.
    Elsamany SA; Al-Fayea TM; Alzahrani AS; Abozeed WN; Darwish W; Farooq MU; Almadani AS; Bukhari EA
    Asian Pac J Cancer Prev; 2015; 16(7):2987-91. PubMed ID: 25854394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
    Myong NH
    J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1201-S1208. PubMed ID: 30539871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma.
    Zhao Q; Xu S; Liu J; Li Y; Fan Y; Shi T; Wei S; Tang SC; Liu H; Chen J
    Onco Targets Ther; 2015; 8():2469-78. PubMed ID: 26388694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid transcription factor-1 in pulmonary cytology].
    Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
    Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2020; 16(4):737-744. PubMed ID: 32930112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between TTF-1 Expression and PFS of Pemetrexed-containing Chemotherapy in Non-squamous-NSCLC Patients With and Without Driver Genes.
    Okauchi S; Miyazaki K; Shiozawa T; Satoh H; Hizawa N
    Cancer Diagn Progn; 2023; 3(1):53-60. PubMed ID: 36632586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.